Health Biotechnology and Biopharma
Health Biotechnology and Biopharma (HBB, ISSN: 2538-4414) is a quarterly peer-reviewed journal which promotes latest research which emphasizes on all areas of health biotechnology and biopharma. It is an open access, peer-reviewed and online scientific journal. The aim of this journal is to provide a platform for researchers to promote innovative research. This journal consists of the following sections:
• BioPharm Hypothesis
• Original Research/ Review Article
• Short Communication/ Opinion/ Letter
In the field of pharmaceutical, biological, medicinal and chemical sciences. Bio/Pharm Hypothesis provides novel and innovative ideas in biopharmaceutics, opening the field to radical hypothesis based on non-experimental and experimental research. We assign all articles to Digital Object Identifier (DOI ) of mEDRA. Please submit your manuscript online.
Publisher:
Health Biotechnology and Biopharma
Editor-in-Chief:
Dr. Soroush Sardari
Executive Manager:
Dr. Masoomeh Shirzad
Frequency: Quarterly
Online ISSN: 2538-4414
Pages 1-12
Pages 13-25
Pages 26-32
Pages 33-52
Pages 53-61
Pages 62-81
Volume 5, Issue 2, September 2021, Pages 1-6
Volume 5, Issue 4, March 2022, Pages 55-85
Volume 6, Issue 1, June 2022, Pages 62-81
Volume 5, Issue 2, September 2021, Pages 46-60
Volume 5, Issue 2, September 2021, Pages 26-33
Articles in Press, Accepted Manuscript, Available Online from 27 June 2022
Articles in Press, Accepted Manuscript, Available Online from 28 June 2022
Articles in Press, Accepted Manuscript, Available Online from 28 June 2022
Articles in Press, Accepted Manuscript, Available Online from 13 July 2022
Articles in Press, Accepted Manuscript, Available Online from 13 July 2022
Articles in Press, Accepted Manuscript, Available Online from 23 July 2022
', './data/hbb/coversheet/cover_en.jpg'))